Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Kensuke Bekku"'
Autor:
Shogo Watari, Satoshi Katayama, Hiromasa Shiraishi, Moto Tokunaga, Risa Kubota, Norihiro Kusumi, Takaharu Ichikawa, Tomoyasu Tsushima, Yasuyuki Kobayashi, Kensuke Bekku, Motoo Araki
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-9 (2023)
Abstract Purpose This study aimed to investigate the effectiveness of the Geriatric Nutritional Risk Index (GNRI) in predicting the efficacy of first-line immune checkpoint inhibitor (ICI) combination therapy for metastatic or unresectable renal cell
Externí odkaz:
https://doaj.org/article/81b977bffc3c4db09ee256231e5e49e7
Autor:
Kazuma Tsuboi, Kensuke Bekku, Kohei Haisa, Yuta Kajihara, Takuji Tsugawa, Yosuke Inoue, Tomoko Sako, Wataru Murao, Shin Ebara
Publikováno v:
IJU Case Reports, Vol 6, Iss 4, Pp 253-256 (2023)
Introduction Urachus carcinoma is a rare malignancy with an aggressive potential and a poor prognosis, and evidence is limited for its diagnosis and treatment. Case presentation A 75‐year‐old man underwent fluorodeoxyglucose positron emission tom
Externí odkaz:
https://doaj.org/article/beb9902f76f74c2ca57b61f21746a289
Autor:
Sever Chiujdea, Matteo Ferro, Mihai Dorin Vartolomei, Giuseppe Lucarelli, Kensuke Bekku, Akihiro Matsukawa, Mehdi Kardoust Parizi, Jakob Klemm, Ichiro Tsuboi, Tamas Fazekas, Stefano Mancon, Shahrokh F. Shariat
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 13, p 3789 (2024)
(1) Background: Intravesical chemotherapy is the standard of care in intermediate-risk non-muscleinvasive bladder cancer (NMIBC). Different agents are used across the world based on availability, cost, and practice patterns. Epirubicin (EPI), one of
Externí odkaz:
https://doaj.org/article/837fed4c42904ada9c4b46aad5afd41e
Autor:
Takafumi Yanagisawa, Pawel Rajwa, Tatsushi Kawada, Kensuke Bekku, Ekaterina Laukhtina, Markus von Deimling, Muhammad Majdoub, Marcin Chlosta, Pierre I. Karakiewicz, Axel Heidenreich, Takahiro Kimura, Shahrokh F. Shariat
Publikováno v:
Current Oncology, Vol 30, Iss 2, Pp 2194-2216 (2023)
(1) Background: Local therapy is highly promising in a multimodal approach strategy for patients with low-volume metastatic prostate cancer (mPCa). We aimed to systematically assess and summarize the safety, oncologic, and functional outcomes of cyto
Externí odkaz:
https://doaj.org/article/d8d7f6a3563f45a6b7a29dda6856ac73
Autor:
Kensuke Bekku, Tatsushi Kawada, Takanori Sekito, Kasumi Yoshinaga, Yuki Maruyama, Tomoaki Yamanoi, Yusuke Tominaga, Takuya Sadahira, Satoshi Katayama, Takehiro Iwata, Shingo Nishimura, Kohei Edamura, Tomoko Kobayashi, Yasuyuki Kobayashi, Motoo Araki, Yuzuru Niibe
Publikováno v:
Cancers, Vol 15, Iss 24, p 5873 (2023)
One-third of renal cell carcinomas (RCCs) without metastases develop metastatic disease after extirpative surgery for the primary tumors. The majority of metastatic RCC cases, along with treated primary lesions, involve limited lesions termed “olig
Externí odkaz:
https://doaj.org/article/f59f6a6e81b74b6f88f72d519d2f5de5
Autor:
Jakob Klemm, Kensuke Bekku, Mohammad Abufaraj, Ekaterina Laukhtina, Akihiro Matsukawa, Mehdi Kardoust Parizi, Pierre I. Karakiewicz, Shahrokh F. Shariat
Publikováno v:
Cancers, Vol 16, Iss 1, p 44 (2023)
Non-metastatic upper urinary tract carcinoma (UTUC) is a comparatively rare condition, typically managed with either kidney-sparing surgery (KSS) or radical nephroureterectomy (RNU). Irrespective of the chosen therapeutic modality, patients with UTUC
Externí odkaz:
https://doaj.org/article/d791c0f483104dd2ab4bc56bff2338f6
Autor:
Takafumi Yanagisawa, Pawel Rajwa, Fahad Quhal, Tatsushi Kawada, Kensuke Bekku, Ekaterina Laukhtina, Markus von Deimling, Marcin Chlosta, Pierre I. Karakiewicz, Takahiro Kimura, Shahrokh F. Shariat
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 4, p 641 (2023)
(1) Background: Several phase II studies, including randomized controlled trials (RCTs), assessed the efficacy of adding androgen receptor signaling inhibitors (ARSIs) to androgen deprivation therapy (ADT) as a neoadjuvant treatment in patients treat
Externí odkaz:
https://doaj.org/article/32a197a3f59946ea8a65876b40cea60d
Autor:
Takafumi Yanagisawa, Manuela Schmidinger, Tatsushi Kawada, Kensuke Bekku, Takahiro Kimura, Shahrokh F. Shariat
Publikováno v:
European Urology Focus. 9:275-277
Autor:
Kensuke, Bekku, Takuji, Tsugawa, Kazuma, Tsuboi, Gaku, Noda, Yousuke, Inoue, Wataru, Murao, Shin, Ebara
Publikováno v:
Acta Medica Okayama. 76(4):465-472
We aimed to identify the role of first-line monotherapy with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKI) in patients with metastatic RCC. Eligible patients were categorized into three groups (favorable, intermed
Autor:
Tatsushi Kawada, Takafumi Yanagisawa, Kensuke Bekku, Ekaterina Laukhtina, Markus von Deimling, Marcin Chlosta, Benjamin Pradere, Jeremy Yuen-Chun Teoh, Marko Babjuk, Motoo Araki, Shahrokh F. Shariat
Publikováno v:
Urologic Oncology: Seminars and Original Investigations.